Cargando…

Case Report: A case of synchronous right upper lobe adenocarcinoma and left lower lobe squamous cell carcinoma treated with immune checkpoint inhibitor plus chemotherapy

Globally, lung cancer is the leading cause of cancer-related mortality. Multiple primary lung cancers (MPLC) account for a very small portion of all primary lung cancer cases. Importantly, a quick and precise differentiation between MPLC and intrapulmonary metastases is directly related to patient p...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yujiao, Yu, Han, Dong, Youhong, Zhang, Dongdong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905415/
https://www.ncbi.nlm.nih.gov/pubmed/36761949
http://dx.doi.org/10.3389/fonc.2023.1062138
_version_ 1784883799017914368
author Liu, Yujiao
Yu, Han
Dong, Youhong
Zhang, Dongdong
author_facet Liu, Yujiao
Yu, Han
Dong, Youhong
Zhang, Dongdong
author_sort Liu, Yujiao
collection PubMed
description Globally, lung cancer is the leading cause of cancer-related mortality. Multiple primary lung cancers (MPLC) account for a very small portion of all primary lung cancer cases. Importantly, a quick and precise differentiation between MPLC and intrapulmonary metastases is directly related to patient prognoses as treatment strategies vary according to pathological type. Synchronous MPLC are most commonly seen in the same lung. Here, we report a rare case of a patient with synchronous MPLC of both lungs. A 67-year-old man, with a 1-month cough and expectoration history, was admitted in our hospital. Computed tomography (CT) chest scan revealed a lower lobe nodule in the left lung and an upper lobe nodule in the right lung. He underwent successive fiberoptic bronchoscopy and CT-guided percutaneous pulmonary aspiration biopsy of both lungs. The pathological diagnosis was squamous cell carcinoma of the left lung and adenocarcinoma of the right lung.
format Online
Article
Text
id pubmed-9905415
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-99054152023-02-08 Case Report: A case of synchronous right upper lobe adenocarcinoma and left lower lobe squamous cell carcinoma treated with immune checkpoint inhibitor plus chemotherapy Liu, Yujiao Yu, Han Dong, Youhong Zhang, Dongdong Front Oncol Oncology Globally, lung cancer is the leading cause of cancer-related mortality. Multiple primary lung cancers (MPLC) account for a very small portion of all primary lung cancer cases. Importantly, a quick and precise differentiation between MPLC and intrapulmonary metastases is directly related to patient prognoses as treatment strategies vary according to pathological type. Synchronous MPLC are most commonly seen in the same lung. Here, we report a rare case of a patient with synchronous MPLC of both lungs. A 67-year-old man, with a 1-month cough and expectoration history, was admitted in our hospital. Computed tomography (CT) chest scan revealed a lower lobe nodule in the left lung and an upper lobe nodule in the right lung. He underwent successive fiberoptic bronchoscopy and CT-guided percutaneous pulmonary aspiration biopsy of both lungs. The pathological diagnosis was squamous cell carcinoma of the left lung and adenocarcinoma of the right lung. Frontiers Media S.A. 2023-01-25 /pmc/articles/PMC9905415/ /pubmed/36761949 http://dx.doi.org/10.3389/fonc.2023.1062138 Text en Copyright © 2023 Liu, Yu, Dong and Zhang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Liu, Yujiao
Yu, Han
Dong, Youhong
Zhang, Dongdong
Case Report: A case of synchronous right upper lobe adenocarcinoma and left lower lobe squamous cell carcinoma treated with immune checkpoint inhibitor plus chemotherapy
title Case Report: A case of synchronous right upper lobe adenocarcinoma and left lower lobe squamous cell carcinoma treated with immune checkpoint inhibitor plus chemotherapy
title_full Case Report: A case of synchronous right upper lobe adenocarcinoma and left lower lobe squamous cell carcinoma treated with immune checkpoint inhibitor plus chemotherapy
title_fullStr Case Report: A case of synchronous right upper lobe adenocarcinoma and left lower lobe squamous cell carcinoma treated with immune checkpoint inhibitor plus chemotherapy
title_full_unstemmed Case Report: A case of synchronous right upper lobe adenocarcinoma and left lower lobe squamous cell carcinoma treated with immune checkpoint inhibitor plus chemotherapy
title_short Case Report: A case of synchronous right upper lobe adenocarcinoma and left lower lobe squamous cell carcinoma treated with immune checkpoint inhibitor plus chemotherapy
title_sort case report: a case of synchronous right upper lobe adenocarcinoma and left lower lobe squamous cell carcinoma treated with immune checkpoint inhibitor plus chemotherapy
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905415/
https://www.ncbi.nlm.nih.gov/pubmed/36761949
http://dx.doi.org/10.3389/fonc.2023.1062138
work_keys_str_mv AT liuyujiao casereportacaseofsynchronousrightupperlobeadenocarcinomaandleftlowerlobesquamouscellcarcinomatreatedwithimmunecheckpointinhibitorpluschemotherapy
AT yuhan casereportacaseofsynchronousrightupperlobeadenocarcinomaandleftlowerlobesquamouscellcarcinomatreatedwithimmunecheckpointinhibitorpluschemotherapy
AT dongyouhong casereportacaseofsynchronousrightupperlobeadenocarcinomaandleftlowerlobesquamouscellcarcinomatreatedwithimmunecheckpointinhibitorpluschemotherapy
AT zhangdongdong casereportacaseofsynchronousrightupperlobeadenocarcinomaandleftlowerlobesquamouscellcarcinomatreatedwithimmunecheckpointinhibitorpluschemotherapy